Similar articles

• Pharmacokinetic and pharmacological studies with tolamolol in man.

  Faulkner JK, Stopher DA, Walden R. Faulkner JK, et al. Br J Clin Pharmacol. 1975 Oct;2(5):423-8. doi: 10.1111/j.1365-2125.1975.tb00551.x. Br J Clin Pharmacol. 1975. PMID: 786354 Free PMC article. Clinical Trial.
• [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].

  Balant L, Gorgia A, Marmy A, Tschopp JM. Balant L, et al. Nephrologie. 1980;1(4):177-82. Nephrologie. 1980. PMID: 6895408 French.
• Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.

  Schäfer M, Mutschler E. Schäfer M, et al. J Chromatogr. 1979 Feb 1;169:477-81. doi: 10.1016/0021-9673(75)85087-4. J Chromatogr. 1979. PMID: 536437 No abstract available.
• Fluorodensitometric determination of nadolol in plasma and urine.

  Schäfer-Korting M, Mutschler E. Schäfer-Korting M, et al. J Chromatogr. 1982 Jul 9;230(2):461-5. doi: 10.1016/s0378-4347(00)80500-9. J Chromatogr. 1982. PMID: 7107792 No abstract available.
• Fluorescent probes for chemical transformations on the single-molecule level.

  Jung G, Schmitt A, Jacob M, Hinkeldey B. Jung G, et al. Ann N Y Acad Sci. 2008;1130:131-7. doi: 10.1196/annals.1430.006. Ann N Y Acad Sci. 2008. PMID: 18596341 Review.